In The News,
Angela Lively quoted in Pink Sheet
Angela Lively quoted in Pink Sheet
Monday, July 24, 2017
***excerpt***
“Industry stakeholders would certainly agree that the Medicare ESRD expanded bundle has stunted the interest in drug innovation in the dialysis market, though it would be difficult to prove such a claim,” ADVI Chief Consulting Officer Angela Lively said.
“While the expanded bundle provides a mechanism for transitional drug add-on payment adjustments for this class, it is unclear if that is significant enough to provide a means to spur continued development in this space.” Lively also pointed out that to date, “we have not seen significant advancements in dialysis, as most of the recent approvals have been in formulation or route of administration changes.”
***end excerpt***
***